AU7435500A - Adenoviral vectors - Google Patents

Adenoviral vectors

Info

Publication number
AU7435500A
AU7435500A AU74355/00A AU7435500A AU7435500A AU 7435500 A AU7435500 A AU 7435500A AU 74355/00 A AU74355/00 A AU 74355/00A AU 7435500 A AU7435500 A AU 7435500A AU 7435500 A AU7435500 A AU 7435500A
Authority
AU
Australia
Prior art keywords
adenoviral vectors
adenoviral
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74355/00A
Inventor
Marc Feldman
Brian Maurice John Foxwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kennedy Trust for Rheumatology Research
Original Assignee
Mathilda and Terence Kennedy Institute of Rheumatology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mathilda and Terence Kennedy Institute of Rheumatology filed Critical Mathilda and Terence Kennedy Institute of Rheumatology
Publication of AU7435500A publication Critical patent/AU7435500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
AU74355/00A 1999-09-22 2000-09-22 Adenoviral vectors Abandoned AU7435500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9922283 1999-09-22
GBGB9922283.8A GB9922283D0 (en) 1999-09-22 1999-09-22 Adenoviral vectors
PCT/GB2000/003645 WO2001021823A2 (en) 1999-09-22 2000-09-22 Adenoviral vector with a reporter gene linked to a regulatory region

Publications (1)

Publication Number Publication Date
AU7435500A true AU7435500A (en) 2001-04-24

Family

ID=10861298

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74355/00A Abandoned AU7435500A (en) 1999-09-22 2000-09-22 Adenoviral vectors

Country Status (3)

Country Link
AU (1) AU7435500A (en)
GB (1) GB9922283D0 (en)
WO (1) WO2001021823A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040132101A1 (en) 2002-09-27 2004-07-08 Xencor Optimized Fc variants and methods for their generation
BRPI0314814C1 (en) 2002-09-27 2021-07-27 Xencor Inc antibody comprising an fc variant
AU2003284382A1 (en) * 2002-11-01 2004-06-07 Mayo Foundation For Medical Education And Research Methods and vectors for controlling gene expression
US7642340B2 (en) 2003-03-31 2010-01-05 Xencor, Inc. PEGylated TNF-α variant proteins
AU2004227937B2 (en) 2003-03-31 2007-09-20 Xencor, Inc Methods for rational pegylation of proteins
US7610156B2 (en) 2003-03-31 2009-10-27 Xencor, Inc. Methods for rational pegylation of proteins
WO2005056759A2 (en) 2003-12-04 2005-06-23 Xencor, Inc. Methods of generating variant proteins with increased host string content and compositions thereof
AU2005227326B2 (en) 2004-03-24 2009-12-03 Xencor, Inc. Immunoglobulin variants outside the Fc region
BRPI0510674A (en) 2004-07-15 2007-12-26 Xencor Inc optimized fc variants
DK2325207T3 (en) 2004-11-12 2017-06-06 Xencor Inc Fc variants with altered binding to FcRn
US8802820B2 (en) 2004-11-12 2014-08-12 Xencor, Inc. Fc variants with altered binding to FcRn
EP4098661A1 (en) 2007-12-26 2022-12-07 Xencor, Inc. Fc variants with altered binding to fcrn
EP2793944A4 (en) 2011-12-23 2015-09-02 Nicholas B Lydon Immunoglobulins and variants directed against pathogenic microbes
US9988439B2 (en) 2011-12-23 2018-06-05 Nicholas B. Lydon Immunoglobulins and variants directed against pathogenic microbes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2300938A1 (en) * 1997-08-20 1999-02-25 Somagenics, Inc. Antisense and antigene therapeutics with improved binding properties and methods for their use

Also Published As

Publication number Publication date
WO2001021823A3 (en) 2001-10-11
WO2001021823A2 (en) 2001-03-29
GB9922283D0 (en) 1999-11-17

Similar Documents

Publication Publication Date Title
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU3306400A (en) Anti-viral vectors
EP1052799A3 (en) Flexible channeliser
AU7435500A (en) Adenoviral vectors
AU5967600A (en) Candystraw
AU2002360353A1 (en) Receptor-targeted adenoviral vectors
AU4115400A (en) Short-circuiter
AU4099699A (en) Improved vectors
AU2023701A (en) Sketcher
AU2804600A (en) Arylaminoalkylamides
AU2333001A (en) Double selection vector
AU5706000A (en) Useful polypeptide
AU2699800A (en) Organoceramics
AU4916900A (en) Benzofuranylsulfonates
AU4561600A (en) Benzofuranylaminoalcohols
AU2145300A (en) Adenoviral vectors
AU4672401A (en) Vectors
AU1901801A (en) Glucofuranoses
AU4435300A (en) Hula-hoop
AU2582200A (en) Windturbine
AU1915601A (en) Periotome
AU2109200A (en) Polypeptide
AU2691400A (en) Virus vector
AU2064201A (en) Carbohydrate-aminated glycoproteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase